PLATINUM INVESTMENT MANAGEMENT LTD
13F Reported Value
ⓘ$396.8M
Holdings
89
Latest Filing
2026-03-31
Filing Quarter
Q1 2026
Portfolio Overview
PLATINUM INVESTMENT MANAGEMENT LTD disclosed 89 positions worth $396.8M in its Form 13F-HR for Q1 2026, led by $ZTO (ZTO Express (Cayman) Inc.) at 12.7% of the equity portfolio, followed by $TCOM and $DDL. During the quarter the fund opened 7 new positions and exited 42 — including a new stake in $AZN and a full exit from $AMZN. The portfolio is most concentrated in Healthcare (29.9% of disclosed assets). All figures are sourced directly from PLATINUM INVESTMENT MANAGEMENT LTD’s Form 13F-HR filing with the SEC under CIK 1256071.
AI Fund Analysis
StableSector Allocation
AUM History
Top Equity Holdings by Value
Quarterly Activity — Q1 2026
Click any card to unlockTop Holdings
- —
Quality
$50.2M1,994,127 sh - —
Quality
$18.9M379,718 sh - —
Quality
$16.7M6,486,507 sh - 82.4
Quality
$9.9M46,439 sh - —
Quality
$9.9M275,000 sh - —
Quality
$9.8M993,612 sh - —
Quality
$9.3M48,088 sh - 86.4
Quality
$8.1M26,186 sh - —
Quality
$8.0M78,445 sh - 88.4
Quality
$8.0M23,656 sh
| Company | Quality | Value | Shares |
|---|---|---|---|
| — | $50.2M | 1,994,127 | |
| — | $18.9M | 379,718 | |
| — | $16.7M | 6,486,507 | |
| 82.4 | $9.9M | 46,439 | |
| — | $9.9M | 275,000 | |
| — | $9.8M | 993,612 | |
| — | $9.3M | 48,088 | |
| 86.4 | $8.1M | 26,186 | |
| — | $8.0M | 78,445 | |
| 88.4 | $8.0M | 23,656 |
Unlock AI quality scores for every holding
32-signal composite ranking on each of PLATINUM INVESTMENT MANAGEMENT LTD's 89 positions.
Showing top 10 of 89 holdings.
Sector Allocation
Healthcare
$118.8M
Industrials
$97.5M
Consumer Discretionary
$61.9M
Technology
$58.7M
Financials
$28.6M
Communication Services
$12.9M
Consumer Staples
$8.8M
Materials
$5.0M
Full Holdings — PLATINUM INVESTMENT MANAGEMENT LTD (Q1 2026)
All 89 disclosed positions from the latest Form 13F-HR, with quarter-over-quarter share changes and 13F Pro quality scores. Sourced from SEC EDGAR.
| # | Ticker | Company | Value | Weight | QoQ | Quality |
|---|---|---|---|---|---|---|
| 1 | ZTO Express (Cayman) Inc. | $50.2M | 12.7% | +0% | — | |
| 2 | Trip.com Group Ltd | $18.9M | 4.8% | -14% | — | |
| 3 | Dingdong (Cayman) Ltd | $16.7M | 4.2% | +0% | — | |
| 4 | LAM RESEARCH CORP | $9.9M | 2.5% | -17% | 82.4 | |
| 5 | Birkenstock Holding plc | $9.9M | 2.5% | +11% | — | |
| 6 | NOAH HOLDINGS LTD | $9.8M | 2.5% | -6% | — | |
| 7 | ASTRAZENECA PLC | $9.3M | 2.4% | NEW | — | |
| 8 | Broadcom Inc. | $8.1M | 2.0% | -15% | 86.4 | |
| 9 | PDD Holdings Inc. | $8.0M | 2.0% | +0% | — | |
| 10 | MICRON TECHNOLOGY INC | $8.0M | 2.0% | -5% | 88.4 | |
| 11 | Merck & Co., Inc. | $7.6M | 1.9% | +0% | 70.9 | |
| 12 | Alphabet Inc. | $7.1M | 1.8% | -33% | 80.2 | |
| 13 | JOHNSON & JOHNSON | $6.8M | 1.7% | +0% | 72.8 | |
| 14 | AbbVie Inc. | $6.5M | 1.6% | +0% | 59.3 | |
| 15 | YUM BRANDS INC | $6.2M | 1.6% | +0% | 71.7 | |
| 16 | CATERPILLAR INC | $6.0M | 1.5% | +55% | 67.8 | |
| 17 | H World Group Ltd | $5.9M | 1.5% | +0% | — | |
| 18 | Terns Pharmaceuticals, Inc. | $5.8M | 1.5% | +0% | — | |
| 19 | ROGERS COMMUNICATIONS INC | $5.6M | 1.4% | +0% | — | |
| 20 | Centessa Pharmaceuticals plc | $5.5M | 1.4% | -11% | — | |
| 21 | Zoetis Inc. | $5.0M | 1.3% | +0% | 72.6 | |
| 22 | Amer Sports, Inc. | $4.9M | 1.2% | -6% | 71 | |
| 23 | NVIDIA CORP | $4.9M | 1.2% | +0% | 90.2 | |
| 24 | Apogee Therapeutics, Inc. | $4.9M | 1.2% | -16% | — | |
| 25 | NETFLIX INC | $4.8M | 1.2% | NEW | 86.7 | |
| 26 | CAMECO CORP | $4.6M | 1.2% | +0% | — | |
| 27 | Vera Therapeutics, Inc. | $4.6M | 1.1% | -5% | — | |
| 28 | IQVIA HOLDINGS INC. | $4.6M | 1.1% | +0% | 59.7 | |
| 29 | VISA INC. | $4.5M | 1.1% | +2% | 83.5 | |
| 30 | Immunovant, Inc. | $4.5M | 1.1% | +0% | — | |
| 31 | ADOBE INC. | $4.5M | 1.1% | +34% | 80.4 | |
| 32 | Valaris Ltd | $4.5M | 1.1% | +0% | — | |
| 33 | UBS Group AG | $4.5M | 1.1% | +0% | — | |
| 34 | KROGER CO | $4.4M | 1.1% | -9% | 51.1 | |
| 35 | e.l.f. Beauty, Inc. | $4.4M | 1.1% | +73% | 53.4 | |
| 36 | Cogent Biosciences, Inc. | $4.3M | 1.1% | -8% | — | |
| 37 | ARROWHEAD PHARMACEUTICALS, INC. | $4.1M | 1.0% | -28% | 74.4 | |
| 38 | HOME DEPOT, INC. | $3.8M | 0.9% | -14% | 69.2 | |
| 39 | Intercontinental Exchange, Inc. | $3.8M | 0.9% | -25% | 73.8 | |
| 40 | ADC Therapeutics SA | $3.7M | 0.9% | +0% | 16.3 | |
| 41 | BridgeBio Pharma, Inc. | $3.7M | 0.9% | +3% | 31.7 | |
| 42 | CAVA GROUP, INC. | $3.6M | 0.9% | +20% | 62.7 | |
| 43 | FAIR ISAAC CORP | $3.6M | 0.9% | -12% | 75.6 | |
| 44 | Alphabet Inc. | $3.5M | 0.9% | -25% | 80.2 | |
| 45 | Floor & Decor Holdings, Inc. | $3.4M | 0.9% | -2% | 53.4 | |
| 46 | Structure Therapeutics Inc. | $3.2M | 0.8% | -24% | — | |
| 47 | COSTAR GROUP, INC. | $3.1M | 0.8% | +19% | 49.5 | |
| 48 | TransUnion | $3.1M | 0.8% | +0% | 69.1 | |
| 49 | IDEAYA Biosciences, Inc. | $3.1M | 0.8% | -24% | 10.5 | |
| 50 | Arcus Biosciences, Inc. | $2.9M | 0.7% | +0% | 12 | |
| 51 | Meta Platforms, Inc. | $2.9M | 0.7% | -29% | 80.9 | |
| 52 | Mastercard Inc | $2.8M | 0.7% | +0% | 81.7 | |
| 53 | Motorola Solutions, Inc. | $2.7M | 0.7% | +47% | 73.8 | |
| 54 | GE Vernova Inc. | $2.7M | 0.7% | +0% | 70.1 | |
| 55 | Dutch Bros Inc. | $2.7M | 0.7% | +40% | 65.9 | |
| 56 | Zymeworks Inc. | $2.6M | 0.7% | +0% | 27.2 | |
| 57 | Roivant Sciences Ltd. | $2.6M | 0.7% | -51% | — | |
| 58 | Vertiv Holdings Co | $2.5M | 0.6% | -16% | 82.7 | |
| 59 | INTUITIVE SURGICAL INC | $2.2M | 0.6% | +0% | 81.4 | |
| 60 | PALISADE BIO, INC. | $2.2M | 0.5% | +85% | — | |
| 61 | KLA CORP | $2.1M | 0.5% | -28% | 84.4 | |
| 62 | Booking Holdings Inc. | $2.1M | 0.5% | +150% | 55.3 | |
| 63 | Revolution Medicines, Inc. | $2.0M | 0.5% | +12% | — | |
| 64 | ProQR Therapeutics N.V. | $2.0M | 0.5% | +0% | — | |
| 65 | Wave Life Sciences Ltd. | $2.0M | 0.5% | +19% | — | |
| 66 | VEEVA SYSTEMS INC | $2.0M | 0.5% | +0% | 77.8 | |
| 67 | Wingstop Inc. | $1.9M | 0.5% | +50% | 75.1 | |
| 68 | IDEXX LABORATORIES INC /DE | $1.7M | 0.4% | +0% | 73.6 | |
| 69 | MICROSOFT CORP | $1.5M | 0.4% | -52% | 83.7 | |
| 70 | ADVANCED MICRO DEVICES INC | $1.5M | 0.4% | +0% | 78.8 | |
| 71 | EchoStar CORP | $1.5M | 0.4% | NEW | 29.5 | |
| 72 | BRIGHT MINDS BIOSCIENCES INC. | $1.4M | 0.3% | -12% | — | |
| 73 | Stoke Therapeutics, Inc. | $1.3M | 0.3% | +0% | 53.4 | |
| 74 | Definium Therapeutics, Inc. | $1.3M | 0.3% | NEW | — | |
| 75 | MBX Biosciences, Inc. | $1.3M | 0.3% | +0% | — | |
| 76 | AMPHENOL CORP /DE/ | $1.2M | 0.3% | NEW | 80.5 | |
| 77 | BOSTON SCIENTIFIC CORP | $1.1M | 0.3% | -9% | 79.9 | |
| 78 | C4 Therapeutics, Inc. | $1.0M | 0.3% | NEW | 6.5 | |
| 79 | Globalstar, Inc. | $941,039 | 0.2% | NEW | 45.2 | |
| 80 | BICYCLE THERAPEUTICS PLC | $856,558 | 0.2% | +0% | — | |
| 81 | JD.com, Inc. | $847,181 | 0.2% | -7% | — | |
| 82 | MeiraGTx Holdings plc | $813,365 | 0.2% | +0% | — | |
| 83 | MODINE MANUFACTURING CO | $787,307 | 0.2% | -79% | 48.8 | |
| 84 | ARVINAS, INC. | $768,786 | 0.2% | +0% | 13.9 | |
| 85 | Aura Biosciences, Inc. | $748,377 | 0.2% | +0% | — | |
| 86 | Absci Corp | $713,292 | 0.2% | +0% | 4.4 | |
| 87 | Alibaba Group Holding Ltd | $537,345 | 0.1% | -20% | — | |
| 88 | CODEXIS, INC. | $431,076 | 0.1% | +0% | 11.3 | |
| 89 | Skye Bioscience, Inc. | $143,260 | 0.0% | +0% | — |
New Positions (7)
Exited Positions (42)
Browse Top Institutional Investors
13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.
to search all 8,700+ institutional filers.
Available Analysis
13F Pro tracks comprehensive institutional data for PLATINUM INVESTMENT MANAGEMENT LTD including:
Track PLATINUM INVESTMENT MANAGEMENT LTD's Full Portfolio
See every holding, quarter-over-quarter changes, sector allocation, and accumulation patterns for PLATINUM INVESTMENT MANAGEMENT LTD and 8,700+ other institutional investors.
Free tier includes full 13F search and fund profiles. Pro starts at $6.67/mo (billed annually).
AI-Powered Hedge Fund Analysis: PLATINUM INVESTMENT MANAGEMENT LTD
13F Pro is an AI hedge fund tracker and stock research platform. For PLATINUM INVESTMENT MANAGEMENT LTD (SEC CIK: 1256071), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.
Every holding in PLATINUM INVESTMENT MANAGEMENT LTD's portfolio is scored on a 32-signal AI quality ranking (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.